Clinical trial
Incidence of Residual Neuromuscular Blockade in Patients With Frailty Undergoing Gynecologic Cancer Surgery
NCT06216002 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Incidence of Residual Neuromuscular Blockade in Patients With Frailty Undergoing Gynecologic Cancer Surgery
- Lead sponsor
- Mahidol University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 12, 2023
- Completion date
- December 31, 2025
- Enrollment
- 356 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
frailty, general anesthetic drug adverse reaction, gynecologic cancer, neuromuscular blockade, surgical complication